USANA (USNA) Q3 2026 Earnings Call Transcript

USANA reported Q3 net sales of $206 million, down 4% year over year, and adjusted EBITDA of $12.1 million, down 13% from $13.8 million. It lowered full-year adjusted EBITDA guidance to approximately $77 million from $80.5 million and reduced Core Nutritional and Rise Wellness sales outlooks, citing fewer Core customers and softer, lumpy Rise orders; Hiya guidance rose to $130 million as subscribers increased 18% sequentially to 195,500. Year-to-date operating cash flow was $45 million and free cash flow was $36 million, and the company ended the quarter with $179 million in cash and no debt.

Analysis

The central issue is whether USANA can replace a weakening distributor-led engine with repeatable consumer acquisition before the legacy base erodes further. Core customer attrition is the more consequential signal: lower incentive spending may support near-term profitability, but if it also weakens recruitment, the savings are temporary and future product launches will have a smaller network to sell through. Southeast Asia’s improvement is encouraging but not yet evidence of a broad-based reversal; China remains a key sensitivity, with currency-adjusted weakness obscured by reported growth.

Hiya is the main option value, but subscriber additions alone do not establish attractive unit economics. Half-price acquisition offers and upfront packaging/marketing costs put payback and retention at the center of the thesis; the call did not provide cohort-level CAC, churn, or contribution margin. Retail expansion could diversify acquisition and smooth DTC economics, but store count and early sales growth need to translate into sustained sell-through and reorders. Rise adds execution risk: lumpy club orders make quarterly guidance fragile, while wider distribution may take time to offset that volatility.

Near term, the outlook reduction and EBITDA correction warrant a cautious reaction, though cash and no debt limit balance-sheet downside. Over 1–3 months, watch Hiya profitability and Rise order timing; over 6–18 months, the test is Core customer stabilization and whether new products improve retention. The contrarian upside is that the market may under-credit Hiya’s cohort value and USANA’s capacity to fund the transition. That case needs disclosed retention/payback evidence, not management confidence alone.

Key Decisions for Investors

• Keep USNA underweight rather than initiate an aggressive outright short immediately: the legacy franchise is deteriorating, but Hiya growth and the cash cushion create meaningful execution upside. Reassess after the next report.
• If USNA rallies on subscriber or retail headlines without evidence of better economics, consider a defined-risk put spread as a tactical bearish expression; cap premium at risk and avoid entering before checking implied volatility and liquidity.
• Track Hiya cohort retention, CAC payback, and segment EBITDA, alongside retail sell-through and reorders. Treat continued subscriber growth without improving contribution economics as a thesis warning, not confirmation.
• Falsify the cautious view if Core active-customer declines stabilize across regions and Hiya delivers sequential EBITDA improvement while retaining new cohorts. Renew downside concern if Core customer attrition accelerates, guidance is cut again, or Rise orders slip into 2027.